Tower Research Capital LLC (Trc) Pep Gen Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Pep Gen Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 6,050 shares of PEPG stock, worth $13,189. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,050
Previous 3,327
81.85%
Holding current value
$13,189
Previous $28,000
21.43%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding PEPG
# of Institutions
59Shares Held
24.7MCall Options Held
0Put Options Held
15K-
Ra Capital Management, L.P. Boston, MA10.7MShares$23.3 Million0.66% of portfolio
-
Rtw Investments, LP New York, NY3.19MShares$6.96 Million0.2% of portfolio
-
Viking Global Investors LP1.48MShares$3.23 Million0.02% of portfolio
-
Suvretta Capital Management, LLC New York, NY1.17MShares$2.56 Million0.19% of portfolio
-
Black Rock Inc. New York, NY1.04MShares$2.26 Million0.0% of portfolio
About PepGen Inc.
- Ticker PEPG
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,631,900
- Market Cap $51.5M
- Description
- PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The company's lead product candidate is PGN-EDO51, an EDO peptide in Phase I clinical trials to treat individuals with Duchenne muscular dystrophy (DMD). It is a...